v3.26.1
Loss per share (Details) - CHF (SFr)
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Veraxa Biotech A G [Member]
Numerator:
Net loss available to common shareholders
SFr (66,613,990)
SFr (28,132,971)
X
- References
No definition available.
+ Details
Name:
cik0002079109_NetIncomeLossAvailableToCommonStockholderBasic
Namespace Prefix:
cik0002079109_
Data Type:
xbrli:monetaryItemType
Balance Type:
credit
Period Type:
duration
X
- References
No definition available.
+ Details
Name:
cik0002079109_NumeratorAbstract
Namespace Prefix:
cik0002079109_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Details
Name:
dei_LegalEntityAxis=cik0002079109_VeraxaBiotechAGMember
Namespace Prefix:
Data Type:
na
Balance Type:
Period Type: